Discover 1,917 paid clinical trials in Arlington, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,917
Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
for
Recurrent or Refractory Solid Tumors, Ewing Sarcoma,
Location: Dallas TX, Oklahoma City OK, Houston TX, Lubbock TX,
Sponsor: South Plains Oncology Consortium
Sex: All
Age: 1 - 20
Code: NCT02013336
Phase1, Recruiting
Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)
for
Non-muscle-invasive Bladder Cancer
Location: Dallas TX, San Antonio TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18 - 70+
Code: NCT05825950
Recruiting
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Standardized Microbiota Transplant Therapy in Crohn's Disease
for
Crohn Disease
Location: Dallas TX, Minneapolis MN
Sponsor: University of Minnesota
Sex: All
Age: 18 - 70+
Code: NCT06631586
Phase2, Recruiting
Study of SGR-3515 In Participants With Advanced Solid Tumors.
for
Advanced Solid Tumor
Location: Dallas TX, Oklahoma City OK, Nashville TN, Chicago IL,
Sponsor: Schrödinger, Inc.
Sex: All
Age: 18+
Code: NCT06463340
Phase1, Recruiting
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
for
Peripheral T-Cell Lymphoma, Not Otherwise Specified,
Location: Dallas TX, Houston TX, St Louis MO, Iowa City IA,
Sponsor: Corvus Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06561048
Phase3, Recruiting
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma